Production (Stage)
Metagenomi, Inc.
MGX
$1.73
$0.074.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.88% | -14.36% | -16.30% | -38.51% | -53.21% |
| Total Depreciation and Amortization | 18.39% | 28.52% | 38.17% | 61.18% | 100.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 353.48% | 2,594.21% | 589.65% | 372.29% | 1,196.30% |
| Change in Net Operating Assets | -57.72% | -125.77% | -181.47% | -169.99% | -147.57% |
| Cash from Operations | -1.80% | -19.32% | -3,252.43% | -1,861.59% | -594.83% |
| Capital Expenditure | 69.15% | 68.27% | 61.01% | 55.77% | 38.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.54% | -253.10% | -22.20% | 125.76% | 121.08% |
| Cash from Investing | 35.69% | -292.76% | -4.27% | 119.71% | 114.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.65% | -- | 31.55% | -8,217.95% | -- |
| Cash from Financing | -103.12% | 8,201.68% | -15.32% | -18.37% | -51.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,310.61% | -153.49% | -288.28% | 123.48% | -80.64% |